@bioinformant.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

BioInformant - Stem Cell Industry News

bioinformant.bsky.social

did:plc:5qoyj5haqyddlfwefpwoqbab

Regenerelle® Issues Response to FDA Untitled Letter - https://bioinformant.com/regenerelle-issues-response/ Regenerelle®, a leader in Wharton’s Jelly Mesenchymal Stromal Cells (WJ-MSCs) & exosomes derived from WJ-MSCs, announced the public release of its full response to the U.S. FDA Untitled Letter dated May 22, 2023.

2025-09-10T01:58:16.755Z